Valuence Merger I announced that today’s shareholder meeting to vote on a deadline extension has been postponed until June 3 at 10 a.m. Eastern.
Shareholders may withdraw redemptions at any time until the vote is taken, the SPAC said.
Valuence wants to stretch its runway up to March 3, 2026.
The SPAC lost more than two-thirds of its shares outstanding to redemptions in connection with the last extension vote a year ago.
Valuence I completed a $200 million IPO in March 2022. Since then, it has focused on life sciences targets based in Asia, though excluding China, Hong Kong and Macau. The SPAC has yet to announce a deal. Read more.
